Week In Review: Sciwind, Sino Biological And Biocytogen Announce Deals
May 11, 2024 at 16:40 PM EDT
Beijing’s Sino Biological completed its $48 million acquisition of Vancouver-based SignalChem Biotech. Additionally, Biocytogen Pharmaceuticals signed a TCR-mimic antibody evaluation and potential licensing agreement with BioCopy AG.
